MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

No Stability Information

Ascorbic acid 50mg tablets (Alliance Healthcare (Distribution) Ltd)

Explore other Ascorbic acid formulations Explore other Ascorbic acid 50mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Ascorbic acid 50mg tablets (Crescent Pharma Ltd)

Explore other Ascorbic acid formulations Explore other Ascorbic acid 50mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Ascorbic acid 50mg tablets (Ennogen Healthcare International Ltd)

Explore other Ascorbic acid formulations Explore other Ascorbic acid 50mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Ascorbic acid 50mg tablets (Medihealth (Northern) Ltd)

Explore other Ascorbic acid formulations Explore other Ascorbic acid 50mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Ascorbic acid 50mg tablets (Phoenix Healthcare Distribution Ltd)

Explore other Ascorbic acid formulations Explore other Ascorbic acid 50mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Ascorbic acid 50mg tablets (Sigma Pharmaceuticals Plc)

Explore other Ascorbic acid formulations Explore other Ascorbic acid 50mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Ascorbic acid 50mg tablets (Zanza Specials International Ltd)

Explore other Ascorbic acid formulations Explore other Ascorbic acid 50mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

Incompatible

Asenapine 10mg sublingual tablets sugar free (Imported)

Explore other Asenapine formulations Explore other Asenapine 10mg sublingual tablets sugar free suppliers

Stability Notes

Sublingual tablets - protect from light and moisture.

Provenance

This compatibility recommendation is derived from Sycrest 10mg sublingual tablets (Organon Pharma (UK) Ltd).

No Stability Information

Asenapine 3.8mg/24hours transdermal patches (Imported)

Explore other Asenapine formulations Explore other Asenapine 3.8mg/24hours transdermal patches suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Asenapine 5.7mg/24hours transdermal patches (Imported)

Explore other Asenapine formulations Explore other Asenapine 5.7mg/24hours transdermal patches suppliers

Stability Notes

There are no stability notes available for this medicine.

Incompatible

Asenapine 5mg sublingual tablets sugar free (Imported)

Explore other Asenapine formulations Explore other Asenapine 5mg sublingual tablets sugar free suppliers

Stability Notes

Sublingual tablets - protect from light and moisture.

Provenance

This compatibility recommendation is derived from Sycrest 5mg sublingual tablets (Organon Pharma (UK) Ltd).

No Stability Information

Asenapine 7.6mg/24hours transdermal patches (Imported)

Explore other Asenapine formulations Explore other Asenapine 7.6mg/24hours transdermal patches suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Aspirin 100mg capsules (Special Order)

Explore other Aspirin formulations Explore other Aspirin 100mg capsules suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Aspirin 25mg capsules (Special Order)

Explore other Aspirin formulations Explore other Aspirin 25mg capsules suppliers

Stability Notes

There are no stability notes available for this medicine.

Compatible with caution

Aspirin 300mg dispersible tablets (A A H Pharmaceuticals Ltd)

Explore other Aspirin formulations Explore other Aspirin 300mg dispersible tablets suppliers

Stability Notes

Drug hydrolyses in moist air and the rate of hydrolysis is increased by heat. Maximum 8 days in MCA.

Print this list

Compatible

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.

Compatible with caution

Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.

Incompatible

Medicines under this category are not suitable for use inside MCAs.

No Stability Information

We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.